Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial

Clinical Therapeutics ◽

10.1016/j.clinthera.2020.10.009 ◽

2020 ◽

Vol 42 (12) ◽

pp. 2266-2279

Author(s):

Min-Kyung Lee ◽

Younghoon Jeon ◽

Sang Sik Choi ◽

Pyung Bok Lee ◽

Yong-Chul Kim ◽

...

Keyword(s):

Clinical Trial ◽

Neuropathic Pain ◽

Controlled Release ◽

Immediate Release ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Phase Iii Clinical Trial ◽

Download Full-text

A multi-center, randomized, double-blind, parallel, active-controlled phase III clinical trial to evaluate the efficacy and safety of controlled-release pregabalin and immediate-release pregabalin in diabetic peripheral neuropathic pain

Endocrine Abstracts ◽

10.1530/endoabs.70.aep249 ◽

2020 ◽

Author(s):

lee Jae Hyuk ◽

Min-Kyung Lee ◽

Hur Yang Im

Keyword(s):

Clinical Trial ◽

Neuropathic Pain ◽

Controlled Release ◽

Immediate Release ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Phase Iii Clinical Trial

Download Full-text

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Epilepsy & Behavior ◽

10.1016/j.yebeh.2020.106962 ◽

2020 ◽

Vol 105 ◽

pp. 106962 ◽

Author(s):

Fenella Kirkham ◽

Stéphane Auvin ◽

Joana Moreira ◽

Helena Gama ◽

Amílcar C. Falcão ◽

...

Keyword(s):

Clinical Trial ◽

Adjunctive Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase ◽

Download Full-text

Faculty of 1000 evaluation for Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718030851.793482493 ◽

2013 ◽

Author(s):

Joanne Jordan ◽

Amanda Nelson

Keyword(s):

Clinical Trial ◽

Sustained Release ◽

Hip Osteoarthritis ◽

Randomised Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Multicentre Phase ◽

Download Full-text

Efficacy and Safety of 400 and 800 mg Etodolac vs. 1,000 mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial

Pain Practice ◽

10.1111/j.1533-2500.2012.00572.x ◽

2012 ◽

Vol 13 (3) ◽

pp. 191-197 ◽

Author(s):

Vesile Öztürk ◽

Mustafa Ertaş ◽

Betül Baykan ◽

Hadiye Şirin ◽

Aynur Özge ◽

...

Keyword(s):

Clinical Trial ◽

Acute Treatment ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase

Download Full-text

Correction to: Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial

Journal of Diabetes & Metabolic Disorders ◽

10.1007/s40200-019-00440-z ◽

2019 ◽

Vol 18 (2) ◽

pp. 583-583

Author(s):

Khojasteh Joharchi ◽

Moosareza Memari ◽

Eznollah Azargashb ◽

Navid Saadat

Keyword(s):

Clinical Trial ◽

Neuropathic Pain ◽

Randomized Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Iranian Patients

The article Efficacy and safety of duloxetine and Pregabalin in Iranian patients with diabetic peripheral neuropathic pain: a double-blind, randomized clinical trial, written by Khojasteh Joharchi, Moosareza Memari, Eznollah Azargashb, and Navid Saadat, was originally published.

Download Full-text

Abstract P3-12-07: A multicenter randomized double-blind phase III clinical trial to evaluate the efficacy and safety of GCPGC, a novel pegylated G-CSF in patients receiving DA or TAC chemotherapy for breast cancer compared to peg-filgrastim

10.1158/1538-7445.sabcs14-p3-12-07 ◽

2015 ◽

Author(s):

Joo Han Lim ◽

Ki-Hyeong Lee ◽

Keon-Uk Park ◽

In-Hae Park ◽

Eun Kyung Cho ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Tac Chemotherapy

Download Full-text

Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study

Epilepsia ◽

10.1111/epi.13993 ◽

2018 ◽

Vol 59 (2) ◽

pp. 479-491 ◽

Author(s):

Eugen Trinka ◽

Elinor Ben-Menachem ◽

Pedro A. Kowacs ◽

Christian Elger ◽

Birgit Keller ◽

...

Keyword(s):

Controlled Release ◽

Multicenter Study ◽

Phase Iii ◽

Newly Diagnosed ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Download Full-text

A Multicenter, Double-Blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of a Cell and Gene Therapy in Knee Osteoarthritis Patients

Human Gene Therapy Clinical Development ◽

10.1089/hum.2017.249 ◽

2018 ◽

Author(s):

Myung-Ku Kim ◽

Chul-Won Ha ◽

Yong In ◽

Sung-Do Cho ◽

Eui-Sung Choi ◽

...

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

Knee Osteoarthritis ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

A Cell ◽

Cell And Gene Therapy

Download Full-text

Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial

Archives of Physical Medicine and Rehabilitation ◽

10.1016/j.apmr.2020.03.025 ◽

2020 ◽

Vol 101 (9) ◽

pp. 1485-1496

Author(s):

Junekyung Lee ◽

Min Ho Chun ◽

Young Jin Ko ◽

Shi-Uk Lee ◽

Deog Young Kim ◽

...

Keyword(s):

Clinical Trial ◽

Active Drug ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Multicenter Phase ◽

Limb Spasticity

Download Full-text

Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension

Clinical Therapeutics ◽

10.1016/j.clinthera.2005.04.001 ◽

2005 ◽

Vol 27 (4) ◽

pp. 441-450 ◽

Author(s):

S PARK ◽

N CHUNG ◽

J KWON ◽

J YOON ◽

Y KIM ◽

...

Keyword(s):

Clinical Trial ◽

Moderate Hypertension ◽

Phase Iii ◽

Amlodipine Besylate ◽

Double Blind ◽

Phase Iii Clinical Trial ◽

Korean Patients ◽

Download Full-text